Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily McFadden

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
BMJ Open|June 15, 2019
Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRDBenjamin Feakins, Jason Oke, Emily McFadden, et al.
British Journal of Cancer|July 29, 2016
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?Michael E Jones, Minouk J Schoemaker, Lauren Wright, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 30, 2026
Missing by omission: the hidden heart of cardiovascular inequity in the UKClare R Goyder, Caroline Mitchell, Charlotte James, et al.
Health Technology Assessment (Winchester, England)|December 19, 2015
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modellingRafael Perera, Emily McFadden, Julie McLellan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
BMJ Open|June 15, 2019
Trends in kidney function testing in UK primary care since the introduction of the quality and outcomes framework: a retrospective cohort study using CPRDBenjamin Feakins, Jason Oke, Emily McFadden, et al.
British Journal of Cancer|July 29, 2016
Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?Michael E Jones, Minouk J Schoemaker, Lauren Wright, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 30, 2026
Missing by omission: the hidden heart of cardiovascular inequity in the UKClare R Goyder, Caroline Mitchell, Charlotte James, et al.
Health Technology Assessment (Winchester, England)|December 19, 2015
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modellingRafael Perera, Emily McFadden, Julie McLellan, et al.
Pageof 4